Keros Therapeutics, Inc. · NASDAQ:KROS

The Vanguard Group reported a 5.00% stake in Keros Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Jan 30, 2026

The Vanguard Group reported a 5.00% stake in Keros Therapeutics, Inc., 1,525,355 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).

Stake
5.00%
Shares
1,525,355
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
The Vanguard Group5.00%1,525,355

Source

View original at SEC

Related